Three of the top pharmaceutical companies have entered agreements to pay the state of California nearly $70 million to settle allegations that they “delayed drugs to keep prices high” according to California Attorney General Xavier Becerra. Most of the funds will come from Teva Pharmaceuticals ($69 million) for paying to delay a generic for Provigil,
Novartis manipulated data to win approval for its spinal muscular atrophy treatment.
Connecticut is joining in on an investigation into JUUL’s marketingn efforts.
The Trump Administration follows the lead of some states and restricts short-term opioid use to seven days.
What do you know about Hepatitis C and its treatment? Being an informed patient is helpful to successful outcomes.
Cardinal Health, McKesson, and AmerisourceBergen have proposed paying $10 billion to settle all claims that they contributed to the opioid crisis. All three opioid distributors have been hit hard with claims that they did not do enough to flag and discontinue shipping large, suspicious orders of addictive drugs. The companies made the verbal proposal with
Opioid settlement needs to have more directon than the tobacco one, experts say.
Arizona decides to take its allegations against Purdue and the Sacklers directly to the Supreme Court.
Generics companies failed to scale back on opioid distribution even when orders were highly suspicious.
Study finds that 50% of new mothers are prescribed opioids and many are still taking them one year later.